Related Experiment Video
Updated: Jun 15, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy
Luciano C Amado1, Joao A C Lima
1Johns Hopkins University, Baltimore, Maryland 21287, USA.
Insights
Contrast-enhanced MRI can identify scar tissue in hypertrophic cardiomyopathy (HCM) patients, predicting arrhythmias and sudden cardiac death risk. This imaging technique shows promise for improved risk stratification in HCM management.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) poses a risk of sudden cardiac death.
- Current methods for identifying high-risk HCM patients are suboptimal.
- Cardiac MRI is an emerging tool in cardiovascular diagnostics.
Purpose of the Study:
- To review the utility of contrast-enhanced MRI in risk stratifying HCM patients.
- To explore MRI's role in predicting adverse outcomes in HCM.
Main Methods:
- Review of existing literature on contrast-enhanced MRI in cardiomyopathy.
- Analysis of studies correlating myocardial scar with prognosis in HCM.
- Evaluation of MRI's predictive value for arrhythmias and sudden cardiac death.
Main Results:
- Myocardial scar, detected by contrast-enhanced MRI, predicts poor prognosis in various cardiomyopathies.
- Evidence suggests scar in HCM is associated with increased risk of arrhythmias and adverse events.
- Contrast-enhanced MRI findings correlate with sudden cardiac death risk in HCM.
Conclusions:
- Contrast-enhanced MRI is a valuable tool for identifying myocardial scar in HCM.
- This imaging modality can aid in the risk stratification of HCM patients.
- MRI has the potential to improve the identification of HCM individuals at risk for sudden cardiac death.
Purpose Of Review:
To provide an overview of the potential use of contrast-enhanced MRI as tool for further risk stratification in patients with hypertrophic cardiomyopathy (HCM).
Recent Findings:
The presence of scar measured by contrast-enhanced MRI has been shown to predict poor prognosis in several models of cardiomyopathy, including ischemic and nonischemic dilated cardiomyopathy. Current strategy to identify HCM patients who are at increased risk for sudden cardiac death is still not ideal. Recent data suggest that the presence of scar measured by contrast-enhanced MRI is a predictor of arrhythmias and poor prognosis in patients with HCM.
Summary:
MRI is a potential technique to help identify HCM patients who are at risk for sudden cardiac death.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction
Mechanism of Cardiac Arrhythmias
Myocarditis I: Introduction
